3136 results for «3066»

Filter By

3136 results

Best clinical cases & Early Career Research Award

17 Nov 2025 – From PCR London Valves 2025

Explore a series of innovative clinical cases highlighting the integration of advanced expertise and AI in managing complex structural heart interventions. This session includes compelling cases such as the use of ANCHOR BASILICA to prevent coronary obstruction, the Lithotripsy-BATMAN technique for mitral valve interventions in calcified...

Best clinical cases & Early Career Research Award

Unusual structural interventions - Part 2

18 Nov 2025 – From PCR London Valves 2025

This session highlights unusual structural interventions in cardiology, featuring comprehensive CT screening for left atrial appendage closure, management of procedural complications, novel access techniques for balloon aortic valvuloplasty, transcatheter treatment of mitral bioprosthetic valve vegetation, and percutaneous ventricular septal rupture closure success criteria.

Featured research - TAVI - Part 12

18 Nov 2025 – From PCR London Valves 2025

This session presents advanced research on transcatheter aortic valve implantation (TAVI), featuring an extensive 30-year in-vitro durability analysis of the Evolut self-expanding valve. It also covers predictive studies on valve-in-valve procedure volumes comparing Japan and the United States, insights into TAVI in patients with left ventricular...

Featured research - TAVI - Part 13

18 Nov 2025 – From PCR London Valves 2025

This session delves into key clinical and procedural advances in TAVI, including the randomized PAF-TAVI trial assessing amiodarone for preventing post-TAVI atrial fibrillation, cost comparisons of balloon-expandable tissue preservation valves versus other devices, leaflet modification methods to reduce coronary obstruction risk, optimization techniques for valve-in-valve TAVI...

Transcatheter tricuspid valve replacement - LIVE Case

18 Nov 2025 – From PCR London Valves 2025

Live case: An 86-year-old male, with a history of PPM, permanent AF, CKD stage 3, and moderately impaired LV function (50–55%), presented with symptomatic torrential mixed TR (tricuspid annular dilatation and pacing lead on the septal leaflet). An Evoque valve was implanted under fluoroscopy and TEE...

Transcatheter tricuspid valve replacement - LIVE Case

TAVI complications - Part 4

18 Nov 2025 – From PCR London Valves 2025

This session focuses on complex complications encountered in TAVI procedures, presenting challenging cases such as combined adverse events, wire-related technical difficulties, differential diagnosis between hypoattenuated leaflet thickening and infective endocarditis one year post-TAVI, issues caused by fractured sheath tips impacting valve expansion, and sinus breaches. These...

From GDMT to TEER: management of secondary mitral regurgitation and the timing of transcatheter intervention

18 Nov 2025 – From PCR London Valves 2025

Delve into the comprehensive management of secondary mitral regurgitation, from guideline-directed medical therapy (GDMT) to transcatheter edge-to-edge repair (TEER). This session elucidates the pathophysiology of atrial and ventricular secondary mitral regurgitation, explores optimized heart failure treatments, and reviews the latest evidence on TEER as a therapeutic...

From GDMT to TEER: management of secondary mitral regurgitation and the timing of transcatheter intervention

TAVI: technical tips and tricks

18 Nov 2025 – From PCR London Valves 2025

This session provides practical technical guidance for TAVI procedures emphasizing multimodality imaging for ultra-low contrast implantation, contrast-free techniques tailored for type 0 bicuspid aortic valves, and innovative bailout strategies for rapid pacing failure. It also covers advanced access management approaches in contrast-zero TAVI and current commissural...

Iatrogenic atrial septum defect closure: a necessary procedure?

18 Nov 2025 – From PCR London Valves 2025

This session addresses the clinical considerations surrounding iatrogenic atrial septal defects (ASDs) resulting from transseptal procedures. It covers prevention of residual defects, diagnostic evaluation, criteria for closure, procedural timing, and management strategies for related complications, supported by illustrative clinical cases demonstrating decision-making nuances.

Complications of mitral TEER

18 Nov 2025 – From PCR London Valves 2025

This session addresses complications associated with mitral transcatheter edge-to-edge repair (TEER), showcasing innovative bailout methods such as snare-assisted retrieval of undeployed devices, managing leaflet perforations with latest-generation devices, cases of valve-adjacent tears, mechanical support considerations when pumps fail, and the clinical impact of iatrogenic fossa ovalis...

TAVI-in-TAVI - Part 2

18 Nov 2025 – From PCR London Valves 2025

This session explores the evolving field of TAVI-in-TAVI interventions, presenting complex cases such as transfemoral TAVI-in-TAVI for degenerated transapical clip-fixed valves in transplanted hearts, management of very late TAVI migration in Bentall de Bono patients, TAVI for degenerated Evolut R valves, stepwise approaches to coronary protection...

Featured research: imaging innovation and device performance in TAVI

18 Nov 2025 – From PCR London Valves 2025

This session presents featured research on TAVI, highlighting long-term outcomes and innovations in transcatheter aortic valve therapy. It includes registry data on mild paravalvular leak impact, five-year evaluations of the Hydra THV, comparisons between deep learning and manual echocardiographic assessments, pacemaker implantation outcomes post-TAVI, and procedural...

Featured research: imaging innovation and device performance in TAVI

Imaging to the rescue

11 Dec 2025 – From GulfPCR-GIM 2025

This session highlighted the pivotal role of advanced intracoronary imaging techniques, particularly OCT, in complex case management such as in-stent restenosis and thrombus evaluation. Through real-world cases, it demonstrated how imaging complements physiology to guide therapeutic decisions, including the use of drug-coated balloons beyond native coronary...

Imaging to the rescue

TAVI: coronary complications

17 Nov 2025 – From PCR London Valves 2025

Focused on coronary complications related to transcatheter aortic valve implantation (TAVI), this session discusses unexpected coronary obstructions, the critical role of PCI expertise in management, and unique procedural challenges such as late delayed obstruction and post-UNICORN complications. It also addresses angiographic nuances and strategies to manage...

Future-proof your TAVI programme: increased need to enhance pathway efficiencies

21 May 2025 – From EuroPCR 2025

Explore evolving guidelines, demographic changes, and new data shaping lifetime TAVI management. Learn precision strategies to optimise patient outcomes before, during, and after TAVI, including post-procedural care and PCI with the Evolut FX+ valve. Discover practical approaches to boost hospital efficiency and embrace innovative technologies that...

Future-proof your TAVI programme: increased need to enhance pathway efficiencies

How do I confidently expand my drug-coated balloon practice?

21 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session challenges the conventional approach to bifurcation PCI and dissection management. Learn why drug-coated balloons (DCB) may offer better long-term outcomes in cases where stents fall short, how DCBs can simplify bifurcation strategies, and why it’s time to rethink which dissections really need...

How do I confidently expand my drug-coated balloon practice?

How to handle the most clinically relevant challenges in TAVI

21 May 2025 – From EuroPCR 2025

This session explores some of the most clinically complex scenarios encountered in TAVI practice. Three real-world cases address key challenges such as intervention sequencing and transcatheter valve selection in patients with combined coronary artery disease and severe aortic stenosis. The session also examines coronary obstruction risk assessment and...

How to handle the most clinically relevant challenges in TAVI

Challenging scenarios in patient with multivessel disease

20 May 2025 – From EuroPCR 2025

Explore challenging clinical scenarios in patients with multivessel coronary artery disease. This session presents complex cases such as coronary aneurysms, failed bypass grafts, limitations of intravascular lithotripsy, and rare pathologies like Takayasu’s arteritis, highlighting decision-making and advanced intervention strategies.

Challenging scenarios in patient with multivessel disease

Integration of CT and IVUS for treatment of coronary artery disease in daily practice: from planning to drug-eluting therapy

22 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session highlights how imaging can drive precision in modern PCI. From CT-guided planning to IVUS-guided drug-eluting balloon interventions, each presentation offers practical insights into optimising patient outcomes. Step-by-step approaches and recorded cases illustrate how to tailor tool and technique selection, while also addressing...

Integration of CT and IVUS for treatment of coronary artery disease in daily practice: from planning to drug-eluting therapy

Innovations in TMVR and Intrepid trial updates

21 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session highlights the evolving role of transcatheter mitral valve replacement, focusing on the clinical potential of mitral regurgitation elimination. Get an overview of the current status of the Intrepid TMVR programme, learn about the transition to the 29Fr transfemoral system, and explore how...

Innovations in TMVR and Intrepid trial updates
Didn’t find what you were looking for?